The fund expansion comes as the company's corporate venturing unit has also recruited two executives, Sam Brasch and Yan Pu.

Johnson & Johnson Development Corporation backs the Israel-based company which specialises in healing wounds - a market need its founders became interested in during the Israel-Lebanon war [pictured].

The executive joins the US healthcare company's corporate venturing unit from Frazier Healthcare Ventures.

US-based diagnostics company Gen-Probe has backed the $20m series C venture funding raised by Roka Bioscience, which was a spin-off from the diagnostics company in 2009.

Argos, which has raised $88.9m from venture investments since 1997, is due to list on Nasdaq.

The pharmaceuticals firm, backed by industry giants Novartis, Eli Lilly and Astellas, will receive further funding from the US government to jointly develop one of its compounds.

Amira has had at least $40m in venture backing since it was founded in 2005.